Cargando…

Editorial: Clinical Therapeutic Development Against Cancers Resistant to Targeted Therapies

Detalles Bibliográficos
Autores principales:	Zhou, Fanfan, Zhu, Hong, Fu, Caiyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790167/ https://www.ncbi.nlm.nih.gov/pubmed/35095531 http://dx.doi.org/10.3389/fphar.2021.816896

Ejemplares similares

Editorial: Novel Therapeutic Target and Drug Development in Neurovascular Retinal Diseases
por: Shao, Zhuo, et al.
Publicado: (2021)

Editorial: Novel therapeutic approaches to target drug resistant tumors
por: Riganti, Chiara, et al.
Publicado: (2023)

Editorial: Therapeutic targeting of splicing variants in cancer
por: Sarvari, Pouya, et al.
Publicado: (2023)

Editorial: Epigenetic regulation and therapy resistance in cancer
por: Zhu, Yongxia, et al.
Publicado: (2023)

Editorial: Sepsis: Basic, Clinical and Therapeutic Approaches
por: Kang, Yan, et al.
Publicado: (2022)

Editorial: The developments of metal-based agents against lung cancer
por: Gou, Yi, et al.
Publicado: (2022)

Editorial: Chemo-Radiation-Resistance in Cancer Therapy
por: Lin, Xiaoping, et al.
Publicado: (2022)

Editorial: Adaptive immune resistance in cancer therapy
por: Jiang, Aimin, et al.
Publicado: (2023)

Editorial: Ferroptosis as new therapeutic targets in cancer: From molecular mechanisms to therapeutic opportunities
por: Chen, Jian, et al.
Publicado: (2022)

Editorial: Matricellular Receptors As Potential Targets in Anti-Cancer Therapeutic Strategies
por: Emonard, Hervé, et al.
Publicado: (2016)

Editorial: Novel small molecules in targeted cancer therapy
por: Li, Rong, et al.
Publicado: (2023)

Editorial: Immunity in the development of anti-cancer drug resistance
por: Meng, Ya, et al.
Publicado: (2022)

Editorial: Epigenetic mechanisms and post-translational modifications as novel therapeutic targets in cancer
por: Shi, Zhi, et al.
Publicado: (2022)

Editorial: Epigenetic drugs and therapeutic resistance for epithelial malignancies
por: Tao, Fangfang, et al.
Publicado: (2023)

Editorial: Novel Therapeutic Targets and Emerging Treatments for Fibrosis
por: Samuel, Chrishan S., et al.
Publicado: (2017)

Editorial: IBD Management—Novel Targets and Therapeutic Perspectives
por: Antonioli, Luca, et al.
Publicado: (2020)

Editorial: Therapeutic and Diagnosis Target Discovery Based on Metabolomics
por: Liu, Linsheng
Publicado: (2022)

Editorial: Plant-based drugs: the potential novel therapeutic intervention against cancer stemness and metastasis
por: Liju, Vijayasteltar B., et al.
Publicado: (2023)

Editorial: Exploring the therapeutic effects of synthetic, semi-synthetic and naturally derived compounds against cancer
por: Feng, Liang, et al.
Publicado: (2023)

Editorial: Novel Therapeutic Interventions Against Infectious Diseases: COVID-19
por: Sakkiah, Sugunadevi, et al.
Publicado: (2022)

Editorial: New therapeutic targets for human placental angiogenesis disease
por: Escudero, Carlos A.
Publicado: (2014)

Editorial: Platelets in Disease: From Biomarkers Discovery to Therapeutic Targets
por: Zhao, Fan, et al.
Publicado: (2022)

Editorial: Antimycobacterial drug discovery: Molecular therapeutics and target identification
por: Gunosewoyo, Hendra, et al.
Publicado: (2022)

Editorial: Novel therapeutic target and drug discovery for neurological diseases
por: Zhao, Kaiyue, et al.
Publicado: (2022)

Editorial: Advances in antimicrobial therapy and combating resistance
por: Ghazi, Islam M., et al.
Publicado: (2023)

Editorial: Cancer of gastrointestinal tract: Novel insight into the molecular mechanisms related to inflammation and therapeutic targets
por: Banerjee, Aditi, et al.
Publicado: (2022)

Editorial: Targeted Immunotherapy for Cancer
por: Williams, Williams V.
Publicado: (2022)

Editorial: New Technologies in Cancer Diagnostics and Therapeutics
por: Li, Haichang, et al.
Publicado: (2021)

Editorial: Novel modalities in cancer diagnostics and therapeutics
por: Zhao, Serena Li, et al.
Publicado: (2022)

Editorial: Ferroptosis as a novel therapeutic target for inflammation-related diseases
por: Liang, Yongyi, et al.
Publicado: (2023)

Editorial: Recent advances in novel therapeutic molecules and targets for inflammatory diseases
por: Li, Feng, et al.
Publicado: (2023)

Editorial: Anakoinosis: An Innovative Anticancer Therapy Targeting the Aberrant Cancer Tissue Homeostasis
por: Heudobler, Daniel, et al.
Publicado: (2021)

Editorial: Targeted cancer therapies, from small molecules to antibodies, volume II
por: Su, Chao-Yue, et al.
Publicado: (2023)

Editorial: Considering plant metabolites and their synthetic derivatives as candidates for the development of drugs against multidrug resistant (MDR) tumors
por: Rijo, Patricia, et al.
Publicado: (2022)

Editorial: Curcuminoids: their pleiotropism against hallmarks of cancers
por: Pouliquen, Daniel L., et al.
Publicado: (2023)

Editorial: New Therapeutic Approaches Against Inflammation and Immune Regulation in Metabolic Related Diseases
por: Lu, Yao, et al.
Publicado: (2022)

Editorial: Antioxidant and neuroprotective potential of alternative and complementary therapeutic approaches against Alzheimer’s disease
por: Singh, Sandeep Kumar, et al.
Publicado: (2023)

Editorial: Antimycobacterial drug discovery: molecular therapeutics and target identification, Volume II
por: Gunosewoyo, Hendra, et al.
Publicado: (2023)

Editorial: Targeting autophagy in Cancer Therapy: Focus on small-molecule modulators and new strategies
por: Pluta, Ryszard
Publicado: (2023)

Editorial: Cancer neuroscience: Drug repurposing targeting the innervated niche
por: Jin, Ming-Zhu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ifq8ikr819a4mgv1ulju9h2g91